MSA-VT Score for Assessment of Long-Term Prognosis after Electrical Storm Ablation.

catheter ablation electrical storm mortality recurrence risk assessment

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 14 01 2024
revised: 18 02 2024
accepted: 21 02 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

Prognosis after electrical storm (ES) ablation remains severe, especially in patients with recurrent sustained monomorphic ventricular tachycardia (SMVT) or progressive heart failure (HF). However, single-factor-based prediction is suboptimal and may be refined by more complex algorithms. We sought to evaluate if a novel score MSA-VT (M = moderate/severe mitral regurgitation, S = severe HF at admission, A = atrial fibrillation at admission, VT = inducible SMVT after ablation) may improve prediction of death and recurrences compared to single factors and previous scores (PAINESD, RIVA and I-VT). A total of 101 consecutive ES ablation patients were retrospectively analyzed over a 32.8-month (IQR 10-68) interval. The MSA-VT score was calculated as the sum of the previously mentioned factors' coefficients based on hazard ratio values in Cox regression analysis. The AUC for death prediction by MSA-VT was 0.84 ( Prediction by single factors and previously published scores after ES ablation may be improved by the novel MSA-VT score; however, this requires further external validation in larger samples.

Identifiants

pubmed: 38540108
pii: biomedicines12030493
doi: 10.3390/biomedicines12030493
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Radu Vatasescu (R)

Department of Cardiothoracic Pathology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cardiology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.

Cosmin Cojocaru (C)

Department of Cardiothoracic Pathology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cardiology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.

Viviana Gondos (V)

Department of Medical Electronics and Informatics, Polytechnic University, 060042 Bucharest, Romania.

Corneliu Iorgulescu (C)

Cardiology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.

Stefan Bogdan (S)

Department of Cardiothoracic Pathology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cardiology Department, Elias University Emergency Hospital, 011461 Bucharest, Romania.

Sebastian Onciul (S)

Department of Cardiothoracic Pathology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cardiology Department, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania.

Antonio Berruezo (A)

Heart Institute, Teknon Medical Center, C/Vilana, 12, 08022 Barcelona, Spain.

Classifications MeSH